[Hyderabad, April 14th, 2025] – The veterinary pain management market is undergoing a paradigm shift, with innovative therapies transforming how we care for aging and post-surgical pets.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-veterinary-pain-management-market/
Market Expansion Highlights
- 2023 Valuation: USD 2.72 billion
- 2031 Projection: USD 5.95 billion
- Key Growth Areas:
- Cannabis-derived products (XX% CAGR)
- Regenerative medicine (USD 1.2B opportunity by 2027)
Innovation Spotlight
- Zoetis’ Librela Breakthrough
- First monthly osteoarthritis injection for dogs
- 70% mobility improvement in clinical trials
- Assisi’s LOOP Laser
- Non-pharmaceutical pain relief
- FDA-cleared for post-op and chronic conditions
- VetCBD’s Nano-Emulsified Oil
- 55% faster absorption vs. traditional CBD
- Zero THC formula approved in 25 states
Regional Adoption Trends
- North America: 80% of specialty clinics now provide multimodal pain management plans
- Europe: Stricter opioid regulations drive alternative therapy adoption
- Japan: Acupuncture reimbursement increases clinic revenues by 20%
Expert Commentary
"Pain management is no longer just about drugs – it’s about personalized, multi-modal care that addresses each pet’s unique needs."
– Dr. Emily Torres, International Veterinary Pain Management Association
Recent Milestones
- Zoetis’ Pain Biomarker Test (Q1 2024 launch)
- Predicts individual drug responses via saliva swab
- FDA’s First Feline NSAID (March 2024 approval)
Future Forecast
- 2025: Stem cell patches for joint pain enter market
- 2027: Wearable pain monitors alert owners to discomfort
- 2030: Gene therapy prevents chronic pain development
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
